Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles - Wikidata - awgldk - TriplyDB

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles

http://www.wikidata.org/entity/Q24236630

about

Different ART outcomes at increasing peak estradiol levels with long and antagonist protocols: retrospective insights from ten years experience.Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.Gonadotropin-releasing hormone agonist for oocyte triggering in endometrial preparation of letrozole stimulation protocols does not affect clinical outcome of frozen-thawed embryo transfer Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study The state of "freeze-for-all" in human ARTs.

P2860

Q35205814-5A43FB31-5342-48D6-8B50-A3F70E99EC2A Q35471131-A48249E1-D088-40EB-B206-3F1070D6DDB4 Q36412114-8FAFA07D-00A6-4E90-8303-7C90244EDC38 Q37035301-92604C47-7606-460F-BE08-2FC9EFB90C20 Q38954609-BDA47C04-7427-4F1A-8FF7-34E22AFD6A27

P2860

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles

http://www.wikidata.org/entity/Q24236630

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Gonadotropin-releasing hormone ...... reproductive technology cycles

@ast

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en-gb

Gonadotropin-releasing hormone ...... reproductive technology cycles

@nl

type

label

Gonadotropin-releasing hormone ...... reproductive technology cycles

@ast

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en-gb

Gonadotropin-releasing hormone ...... reproductive technology cycles

@nl

prefLabel

Gonadotropin-releasing hormone ...... reproductive technology cycles

@ast

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en-gb

Gonadotropin-releasing hormone ...... reproductive technology cycles

@nl

P1433

Q24236630-8DC40776-2C14-483F-93B1-3A6A8C790CB7

P1476

Q24236630-33093B17-F209-47BC-9B5D-6F8BC3F50836

P2093

Q24236630-669B2641-D82F-4C16-999A-5A7BF0F992D2

Q24236630-8C2B91F0-2FDD-4135-8A42-238C0420EDD7

Q24236630-BFD40E22-E986-4D10-BD88-1A8EE091B99C

Q24236630-F0238BF6-92E5-449A-A736-ADC516A7D85A

P2860

Q24236630-0A8F1555-9075-44D4-AD17-702B340FA3F4

Q24236630-0C0B322E-1987-4B28-BF00-37F89F76AC6A

Q24236630-0E829D7A-B3DD-4945-B528-2C1E300D1DF3

Q24236630-2A23C615-4D2D-419D-94D7-B4A629AEF173

Q24236630-2E725979-27BF-4BF8-AA26-ED5D3A659CAB

Q24236630-35004EB1-DEA1-4E39-9A15-A7EAD700040B

Q24236630-3F7219A8-86FB-4439-8218-B63DDEB51B4E

Q24236630-4C0FD9F4-2B07-4198-A4DF-1C8A9A9E67BD

Q24236630-5D804DF7-AD3B-47B2-AE78-6499E5910B86

Q24236630-69A7915B-D59E-453D-BCF2-BB178F8AD253

P31

Q24236630-0C920B43-87C3-40A3-823B-21CD9E241EA2

Q24236630-748c1cc1-7151-4482-982e-8956d501edfe

P356

Q24236630-D6E109DA-AB47-4098-9E73-E26B0E761128

P50

Q24236630-2D029816-7020-4EA9-89AC-21F2B9735379

Q24236630-65971A16-266A-47C4-8BF1-DE0537921BD2

P577

Q24236630-64AC15E4-88B4-4AE7-96B4-AA19ADECB7CD

P5875

Q24236630-DEB71EA9-B2E4-493C-86BB-41AF90692FEF

P698

Q24236630-A63CF674-DBBE-4445-8A64-A1CBB9C14626

P356

14651858.CD008046.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Gonadotropin-releasing hormone ...... reproductive technology cycles

@en

P2093

Georg Griesinger

http://www.w3.org/2001/XMLSchema#string

Hesham G Al-Inany

http://www.w3.org/2001/XMLSchema#string

Mohamed AFM Youssef

http://www.w3.org/2001/XMLSchema#string

Monique H Mochtar

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.

Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo.

Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).

Use of gonadotrophin-releasing hormone agonists to trigger ovulation.

Impact of ovarian stimulation on corpus luteum function and embryonic implantation.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.

Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome.

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

P31

scholarly article

P356

10.1002/14651858.CD008046.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

Madelon van Wely

Fulco Van der Veen

P577

2010-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47743833

http://www.w3.org/2001/XMLSchema#string

P698

21069701

http://www.w3.org/2001/XMLSchema#string